| Bioactivity | GSK-364735 sodium (S/GSK-364735 sodium) is the sodium salt form of GSK-364735 (HY-16907). GSK-364735 sodium is an antiretroviral, that inhibits the integrase of human immunodeficiency virus type 1 (HIV-1) with an IC50 of 7.8 nM[1]. |
| Target | IC50: 7.8 nM (HIV-1 integrase) |
| CAS | 863437-78-9 |
| Formula | C19H18FN3NaO4 |
| Molar Mass | 394.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Garvey EP, et al., The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral. Antimicrob Agents Chemother. 2008 Mar;52(3):901-8. |
GSK-364735 sodium
CAS: 863437-78-9 F: C19H18FN3NaO4 W: 394.35
GSK-364735 sodium (S/GSK-364735 sodium) is the sodium salt form of GSK-364735 (HY-16907). GSK-364735 sodium is an antire
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.